(Q74275286)
Statements
Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group (English)
R B Belshe
G J Gorse
M J McElrath
T J Matthews
R H Hsieh
L Corey
D J Kennedy
M C Walker
1 March 1998